In the past few weeks, the diabetes community has suffered several tragedies in losing young people to diabetes. It is shocking and upsetting when diabetes takes the life of anyone, but somehow more so when it cuts a young life so short. Moira McCarthy Stanford is a journalist, a long-time JDRF volunteer and mom to Leigh, 22, and Lauren, 18 — who was diagnosed with type 1 at age 5. Today, Lauren is one of…Read more »
Today, another example of the more things change, the more they stay the same:
In his new book Diabetes Rising, journalist Dan Hurley reports about skyrocketing numbers of children being diagnosed with Type 1 diabetes in a wealthy Boston suburb. Parents there are desperate for answers as to why this is happening, yet “the lack of a national or even statewide diabetes registry complicates efforts… we know little about what causes Type 1 diabetes.”
Earlier this week, I got word that a woman who called herself “Goddess” online has passed away. She had over 6,000 friends on the DiabeticConnect community site. To be honest, I didn’t know much about her other than the tips and questions she posted very regularly. Still, it’s the oddest (and saddest) sensation when any life disappears like that.
Another member sent a query saying there still seemed to be activity on Goddess’ profile, and…
When the JDRF recently announced its newest artificial pancreas push — a partnership with Animas and Dexcom to actually develop a commercial product — head of the project Aaron Kowalski kindly agreed to answer reader questions here.
Today, I bring you those answers, direct “from the horses’ mouth,” as it were.
Q) How much more advanced will this be than the Medtronic Paradigm Veo system launched in Europe, which stops insulin delivery for…
At the end of last year (so, basically, two weeks ago), the Juvenile Diabetes Research Foundation announced a joint partnership with the Johnson & Johnson Corporate Office of Science and Technology to help with the discovery and development of drugs to promote beta cell survival. The program will look to fund research at academic centers around the world that could eventually lead to novel new drugs for the prevention and treatment of type 1 diabetes.…Read more »